期刊文献+

桥粒芯糖蛋白3刺激下寻常型天疱疮患者外周血T淋巴细胞增殖检测分析 被引量:3

Proliferation of desmoglein 3-stimulated T lymphocytes from patients with pemphigus vulgaris
原文传递
导出
摘要 目的 观察桥粒芯糖蛋白3(Dsg3)对寻常型天疱疮(PV)患者外周血T淋巴细胞增殖的影响.方法 PV患者12例,正常人22例,提取外周血单一核细胞(PBMC),采用流式细胞仪技术分别检测Dsg3刺激下PBMC中T淋巴细胞亚群变化及T淋巴细胞增殖情况,分析PV患者与正常人之间存在的差异.结果 PV患者PBMC在Dsg3刺激下Th2型T淋巴细胞所占比例为12.17%±5.32%,Th1型T淋巴细胞所占比例为4.08%±1.50%;未经Dsg3刺激的阴性对照组分别为9.84%±5.41%和3.91%±1.38%.PV患者PBMC在Dsg3刺激和无Dsg3刺激时的Th2型T淋巴细胞所占比例均显著高于正常人(P〈O.05);Dsg3刺激下PV患者T淋巴细胞发生增殖,CD4^+T淋巴细胞增殖率为4.65%±3.28%,显著高于正常人(P〈0.05). 结论 Dsg3可诱导PV患者CD4^+T淋巴细胞发生特异性增殖,且主要为Th2优势型. Objective To investigate the impact of desmoglein 3 (Dsg3) on the proliferation of peripheral T lymphocytes from patients with pemphigus vulgaris (PV).Methods Peripheral blood mononuclear cells (PBMCs) were obtained from 12 patients with PV and 22 normal human controls,cultured with or without the presence of Dsg3 or phytohemagglutinin for 3 days.Flow cytometry was performed to detect the changes of T-lymphocyte subsets in PBMCs stimulated with Dsg3 and proliferation of T-lymphocytes.Results In patients with PV,the percentage of Th2 and Th1 cells was 12.17%±5.32% and 4.08%±1.50%,respectively in Dsg3stimulated PBMCs,9.84%±5.41% and 3.91%±1.38%,respectively in non-stimulated PBMCs.Increased percentage of Th2 cells was observed in Dsg3-stimulated and non-stimulated PBMCs from patients with PV compared with those from normal human controls (both P〈0.05).After stimulation with Dsg3,there was a significant proliferation of T cells from patients,and the proliferation rate of CD4^+T cells was 4.65%±3.28%,which was significantly higher than that from normal controls(P〈0.05).Conclusion Dsg3 can induce the specific proliferation of CD4^+T cells,especially Th2 type CD+4 T cells,from patients with PV.
出处 《中华皮肤科杂志》 CAS CSCD 北大核心 2010年第7期474-477,共4页 Chinese Journal of Dermatology
基金 国家自然科学基金(30471576),教育部创新团队支持计划项目(IRT0760)
关键词 天疱疮 桥粒芯糖蛋白质3 T淋巴细胞 TH1细胞 TH2细胞 Pemphigus Desmoglein 3 T-lymphocytes Th1 cells Th2 cells
  • 相关文献

参考文献10

  • 1Kárpáti S,Anmgai M,Prussick R,et al.Pemphigus vulgafis antigen,a desmoglein type of cadherin,is localized within keratinocyte desmosomes.J Cell Biol,1993,122(2):409-415.
  • 2Black M,Mignogna D,Scully C.Number Ⅱ pemphigus vulgaris.J Oral Dis,2005,11(3):119-130.
  • 3Amagai M,Koch PJ,Nishikawa T,et al.Pemphigus vulgaris antigen (desmoglein 3) is localized in the lower epidermis,the site of blister formation in patients.J Invest Dermatol,1996,106(2):351-355.
  • 4孙峥嵘,耿龙,吉耀华,徐媛媛,翟宁,阮强,陈洪铎.寻常型天疱疮抗原Dsg3基因的真核表达[J].中华皮肤科杂志,2007,40(9):552-554. 被引量:5
  • 5López-Robles E,Avalos-Díaz E,Vega-Memije E,et al.TNFalpha and IL-6 are mediators in the blistering process of pemphigus.Int J Dermatol,2001,40(3):185-188.
  • 6Caproni M,Giomi B,Cardinali C,et al.Further support for a role for Th2-like cytokines in blister formation of pemphigus.Clin Immunol,2001,98(2):264-271.
  • 7D'Auria L,Bonifati C,Mussi A,et al.Cytokines in the sera of patients with pemphigus vulgaris:interleukin-6 and tumour nocrosis factor-alpha levels are significantly increased as compared to healthy subjects and correlate with disease activity.Eur Cytokine Netw,1997,8(4):383-387.
  • 8Bhol KC,Rojas AI,Khan IU,et al.Presence of interleukin 10 in the serum and blister fluid of patients with pemphigus vulgaris and pemphigoid.Cytokine,2000,12(7):1076-1083.
  • 9Veldman CM,Gebhard KL,Uter W,et al.T cell recognition of desmoglein 3 peptides in patients with pomphigus vulgaris and healthy individuals.J Immunol,2004,172(6):3883-3892.
  • 10Liu Z,Li N,Diaz LA.Inhibition of pemphigus vulgaris by targeting of the CD40-CD154 co-stimulatory pathway:a step toward antigen-specific therapy? J Invest Dermatol,2006,126(1):11-13.

二级参考文献7

  • 1耿龙,孙峥嵘,肖汀,翟宁,牛红喜,宋芳吉.寻常型天疱疮抗原Dsg3 EC1-EC2片段的重组表达[J].中华微生物学和免疫学杂志,2006,26(3):278-278. 被引量:1
  • 2Amagai M, Klaus-Kovtun V, Stanley JR. Autoantibodies against a novel epithelial cadhefin in pemphigus vulgafis, a disease of cell adhesion. Cell, 1991, 67(5): 869-877.
  • 3Karpati S, Amagai M, Prussick R, et al. Pemphigus vulgaris antigen, a desmoglein type of cadherin, is localized within keratinocyte desmosomes. J Cell Biol, 1993, 122(2): 409-415.
  • 4萨姆布鲁克J.弗里奇EF,曼尼阿蒂斯T.分子克隆.金冬雁,译.第二版.北京:科学出版社.1996.
  • 5Amagai M, Hashimoto T, Shimizu N, et al. Absorption of pathogenic autoantibodies by the extracellular domain of pemphigus vulgaris antigen (Dsg3) produced by baculovirus. J Clin Invest, 1994, 94 (1): 59-67.
  • 6Ishii K, Amagai M, Hall RP, et al. Characterization of autoantibodies in pemphigus using antigen-specific enzyme-linked immunosorbent assays with baculovirus-expressed recombinant desmogleins. J Immunol, 1997, 159(4): 2010-2017.
  • 7耿龙,刘海军,梁再赋,李忠民,宋芳吉,陈洪铎.寻常型天疱疮患者一级亲属循环天疱疮抗体的检测分析[J].中华医学杂志,2000,80(10):756-758. 被引量:7

共引文献4

同被引文献26

  • 1Blair PA, Norefia LY, Flores-Borja F, et al. CD19+CD24hiCD38hi B ceils exhibit regulatory capacity in healthy individuals but are functionally impaired in systemic lupus erythematosus patients. Immunity, 2010, 32( 1 ):129-140.
  • 2Murrell DF, Dick S, Ahmed AR, et al. Consensus statement on definitions of disease, end points, and therapeutic response for pemphigus. J Am Acad Dermatol, 2008, 58(6): 1043-1046.
  • 3Pftitze M, Niedermeier A, Hertl M, et al. Introducing a novel Autoimmune Bullous Skin Disorder Intensity Score (ABSIS) in pemphigus. Eur J Dermatol, 2007, 17( 1 ): 4-11.
  • 4Katz SI, Parker D, Turk JL. B-cell suppression of delayed hyper- sensitivity reactions. Nature, 1974, 251 (5475): 550-551.
  • 5Neta R, Salvin SB. Specific suppression of delayed hypersensiti- vity: the possible presence of a suppressor B cell in the regulation of delayed hypersensitivity. J Immunol, 1974, 113(6): 1716-1725.
  • 6Mizoguchi A, Bhan AK. A case for regulatory B cells. J Immunoi, 2006, 176(2): 705-710.
  • 7Yanaba K, Bouaziz JD, Haas KM, et al. A regulatory B cell subset with a unique CDldhiCD5+ phenotype controls T celldependent inflammatory responses. Immunity, 2008, 28(5 ): 639-650.
  • 8Iwata Y, Matsushita T, Horikawa M, et al. Characterization of a rare IL-10-competent B-cell subset in humans that parallels mouse regulatory B10 cells. Blood, 2011, 117(2): 530-541.
  • 9Bouaziz J-D, Calbo S, Maho-Vaillant M, et al. IL-10 produced by activated human B cells regulates CD4 (+) T-cell activation in vitro. Eur J Immunol, 2010, 40( 10): 2686-2691.
  • 10Zhu H, Chen Y, Zhou Y, et al. Cognate Th2-B cell interaction is essential for the autoantibody production in pemphigus vulgaris. J Clin Immunol, 2012, 32(1 ): 114-123.

引证文献3

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部